Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis-Reference-Cited by-同舟云学术

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

Published:2018-08 Issue:8 Volume:76 Page:539-554
ISSN:1678-4227
Container-title:Arquivos de Neuro-Psiquiatria
language:
Short-container-title:Arq. Neuro-Psiquiatr.

Author:

Marques Vanessa Daccach¹,Passos Giordani Rodrigues dos²,Mendes Maria Fernanda¹,Callegaro Dagoberto¹,Lana-Peixoto Marco Aurélio³,Comini-Frota Elizabeth Regina⁴,Vasconcelos Cláudia Cristina Ferreira⁵,Sato Douglas Kazutoshi²,Ferreira Maria Lúcia Brito⁶,Parolin Mônica Koncke Fiuza⁷,Damasceno Alfredo⁸,Grzesiuk Anderson Kuntz⁹,Muniz André¹⁰,Matta André Palma da Cunha¹¹,Oliveira Bianca Etelvina Santos de¹²,Tauil Carlos Bernardo¹³,Maciel Damacio Ramón Kaimen¹⁴,Diniz Denise Sisteroli¹⁵,Corrêa Eber Castro¹⁶,Coronetti Fernando¹⁷,Jorge Frederico M. H.¹,Sato Henry Koiti¹⁸,Gonçalves Marcus Vinícius Magno¹⁹,Sousa Nise Alessandra de C.²⁰,Nascimento Osvaldo J. M.¹¹,Gama Paulo Diniz da²¹,Domingues Renan²²,Simm Renata Faria¹,Thomaz Rodrigo Barbosa²³,Morales Rogério de Rizo²⁴,Dias Ronaldo Maciel²⁵,Apóstolos-Pereira Samira dos¹,Machado Suzana Costa Nunes²⁶,Junqueira Thiago de Faria²⁷,Becker Jefferson²⁸

Affiliation:

1. Universidade de São Paulo, Brasil

2. Pontifícia Universidade Católica do Rio Grande do Sul, Brasil

3. Universidade Federal de Minas Gerais, Brasil

4. Universidade José do Rosário Vellano, Brasil

5. Universidade Federal do Estado do Rio de Janeiro, Brasil

6. Hospital da Restauração, Brasil

7. Clínica Gonçalves Dias, Brasil

8. Universidade de Campinas, Brasil

9. Clínica Privada, Brasil

10. Hospital São Rafael, Brasil

11. Universidade Federal Fluminense, Brasil

12. Fundação Centro Integrado de Apoio ao Portador de Deficiência, Brazil

13. Universidade de Brasília, Brasil; Universidade Católica de Brasília, Brasil

14. Santa Casa de Misericórdia de Londrina, Brasil

15. Universidade Federal de Goiás, Brasil

16. Clínica de Neurologia e Endocrinologia, Brasil

17. Universidade Estadual Paulista, Brasil

18. Instituto de Neurologia de Curitiba, Brasil

19. Universidade da Região de Joinville, Brasil

20. Universidade Federal do Amazonas, Brazil

21. Pontifícia Universidade Católica de São Paulo, Brasil

22. Senne Líquor Diagnóstico, Brasil; Hospital Cruz Azul, Brasil; Faculdade São Leopoldo Mandic, Brasil

23. Hospital Israelita Albert Einstein, Brasil

24. Universidade Federal de Uberlândia, Brasil

25. Hospital de Base do Distrito Federal, Brasil

26. Imperial Hospital de Caridade, Brasil

27. Escola Bahiana de Medicina e Saúde Pública, Brasil

28. Pontifícia Universidade Católica do Rio Grande do Sul, Brasil; Universidade Federal Fluminense, Brasil

Abstract

ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment and Research in Multiple Sclerosis and the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology have convened to establish this Brazilian Consensus for the Treatment of MS, based on their understanding that neurologists should be able to prescribe MS DMTs according to what is better for each patient, based on up-to-date evidence and practice. We herein propose practical recommendations for the treatment of MS, with the main focus on the choice and management of DMTs, as well as present a review of the scientific rationale supporting therapeutic strategies in MS.

Publisher

FapUNIFESP (SciELO)

Subject

Neurology,Clinical Neurology

Link

http://www.scielo.br/pdf/anp/v76n8/0004-282X-anp-76-08-0539.pdf

Reference125 articles.

1. Atlas of MS 2013: mapping multiple sclerosis around the world,2013

2. Evolving concepts in the treatment of relapsing multiple sclerosis;Comi G;Lancet,2017

3. Secretaria de Atenção à Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Portaria Conjunta Nº 10, de 2 de abril de 2018. Aprova o protocolo clínico e diretrizes trapêuticas da esclerose múltipla,2018

4. [Recommendations for the use of immunomodulatory drugs in multiple sclerosis: the BCTRIMS consensus];Tilbery CP;Arq Neuropsiquiatr,2000

5. [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: I. The evidences for the use of immunosuppressive agents, plasma exchange and autologous hematopoietic stem cell transplantation];Callegaro D;Arq Neuropsiquiatr,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A qualidade de vida de pessoas com esclerose múltipla em Portugal;Revista Cuidarte;2024-08-08

2. Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach;Neurology and Therapy;2024-06-01

3. Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption;Journal of Neurology;2024-04-14

4. Decreased functional mobility in individuals with mild to moderate expanded disability status from relapsing multiple sclerosis: Analysis of the Glittre-ADL test;Physiotherapy Theory and Practice;2024-01-02

5. Pattern of disease-modifying therapies use and related adverse events among multiple sclerosis patients;Brazilian Journal of Pharmaceutical Sciences;2024